CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Shares withheld for taxes SVP, CLO, Alkermes, Inc. gave up 1,938 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Alks Inc; CFO ALKS gave up 2,076 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Finance & CAO, Alks Inc. gave up 1,693 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director and CEO, Alkermes plc sold 100,000 shares at $19.50 ($1,950,000)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 20,000 shares at $19.70 ($394,056)
- 4 Open-market sale Director and CEO, Alkermes plc sold 100,000 shares at an average $19.78 ($1,978,445)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 20,000 shares at $19.76 ($395,116)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director and CEO, Alkermes plc sold 100,000 shares at $21.54 ($2,153,550)
- 4 Exercise or conversion SVP, Alks Inc; CFO ALKS acquired 20,000 shares (option exercise)
- 4 Open-market sale Director and CEO, Alkermes plc sold 100,000 shares at $22.68 ($2,268,220)
- 4 Open-market sale Director and CEO, Alkermes plc sold 100,000 shares at $20.18 ($2,017,830)
- 4 Exercise or conversion Director acquired 7,000 shares (option exercise)
- 4 Shares withheld for taxes SVP, Med Dev/Med Affairs, CMO gave up 368 shares (to pay taxes)
- 4 Open-market sale Director and CEO, Alkermes plc sold 110,000 shares at an average $24.88 ($2,736,428)
- 4 Derivatives Options or other derivatives
Page 22 of 67 · 1,323 filings